Its announcement will come within the heels of a similar licensing arrangement provided in February to Adastra Labs, which experienced till now centered on crafting cannabis extracts. The licensing deal comes after a radical policy shift to deal with an opioid overdose crisis that has killed 1000's, by decriminalizing smaller quantities of copy